RPG Life Sciences added 3.84% to Rs 1529.60 after ICRA upgraded the company’s long-term (LT) rating to ‘[ICRA] A+’ from ‘[ICRA] A’ with ‘stable’ outlook.
Subscribe To Our Free Newsletter |
RPG Life Sciences added 3.84% to Rs 1529.60 after ICRA upgraded the company’s long-term (LT) rating to ‘[ICRA] A+’ from ‘[ICRA] A’ with ‘stable’ outlook.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!